BackgroundCheck.run
Search For

Steven Vance Dow, 674810 Lancashure Ln, Tallahassee, FL 32309

Known as:
Steven V Dow Steven U Dow Steve V Dow
Related to:
Yvonne O Dow Mandi J Cheesman 56 Thomas Cheesman 59

Steven Dow Phones & Addresses

4810 Lancashure Ln, Tallahassee, FL 32309    850-5662023   

Moore, OK   

Littleton, CO   

Wheat Ridge, CO   

Houston, TX   

Spring, TX   

Mustang, OK   

Evergreen, CO   

Education

Degree: Doctor of Jurisprudence/Juris Doctor (J.D.) School / High School: Southern Methodist University, Dedman School of Law

Ranks

Licence: Texas - Eligible To Practice In Texas Date: 1987
Get Report
Control this profile

Mentions for Steven Vance Dow

Career records & work history

Lawyers & Attorneys

Steven Dow Photo 1

Steven Michael Dow - Lawyer

Licenses:
Texas - Eligible To Practice In Texas 1987
Education:
Southern Methodist University, Dedman School of LawDegree Doctor of Jurisprudence/Juris Doctor (J.D.)Graduated 1987
Specialties:
Probate - 100%

License Records

Steven Lynn Dow

Licenses:
License #: 76369 - Active
Category: Nursing Support
Issued Date: Sep 27, 2013
Effective Date: Sep 27, 2013
Expiration Date: Sep 27, 2017
Type: Medication Aide

Steven Dow resumes & CV records

Resumes

Steven Dow Photo 42

Senior Pastor At First Church Of God

Location:
United States
Steven Dow Photo 43

Steven Dow

Steven Dow Photo 44

Steven Dow

Publications & IP owners

Us Patents

Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes

US Patent:
6693086, Feb 17, 2004
Filed:
Jun 25, 1998
Appl. No.:
09/104759
Inventors:
Steven W. Dow - Littleton CO
Robyn E. Elmslie - Littleton CO
Assignee:
National Jewish Medical and Research Center - Denver CO
International Classification:
A61K 4800
US Classification:
514 44, 424450, 4353201, 435455, 536 231
Abstract:
This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, or an infectious disease. Also disclosed are therapeutic compositions useful in such a method.

Methods Of Using Nucleic Acid Vector-Lipid Complexes

US Patent:
7741300, Jun 22, 2010
Filed:
Dec 27, 2005
Appl. No.:
11/320019
Inventors:
Steven W. Dow - Littleton CO, US
Robyn E. Elmslie - Littleton CO, US
Jurgen Karl Johannes Schwarze - Witten, DE
Erwin W. Gelfand - Englewood CO, US
Assignee:
National Jewish Medical and Research Center - Denver CO
International Classification:
A61K 48/00
C12N 15/88
C12N 15/63
US Classification:
514 44R, 435458, 4353201
Abstract:
This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, an infectious disease, or a condition associated with a deleterious activity of a self-antigen. Also disclosed are therapeutic compositions useful in such a method.

Vaccines Using Nucleic Acid-Lipid Complexes

US Patent:
2003002, Jan 30, 2003
Filed:
Nov 30, 2001
Appl. No.:
10/012597
Inventors:
Steven Dow - Littleton CO, US
Robyn Elmslie - Littleton CO, US
Jurgen Johannes Schwarze - Witten DE, US
Erwin Gelfand - Englewood CO, US
International Classification:
A61K048/00
A61K009/127
A61K039/00
US Classification:
514/044000, 424/185100, 424/450000
Abstract:
This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, an infectious disease, or a condition associated with a deleterious activity of a self-antigen. Also disclosed are therapeutic compositions useful in such a method.

Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes

US Patent:
2004015, Aug 12, 2004
Filed:
Feb 5, 2004
Appl. No.:
10/772913
Inventors:
Steven Dow - Littleton CO, US
Robyn Elmslie - Littleton CO, US
Jurgen Schwarze - Witten, DE
Erwin Gelfand - Englewood CO, US
International Classification:
A61K048/00
A61K009/127
US Classification:
514/044000, 424/450000
Abstract:
This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, or an infectious disease. Also disclosed are therapeutic compositions useful in such a method.

Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes

US Patent:
2004024, Dec 9, 2004
Filed:
Feb 17, 2004
Appl. No.:
10/780114
Inventors:
Steven Dow - Littleton CO, US
Jeffery Fairman - Mountain View CA, US
International Classification:
A61K048/00
A61K009/127
C12N015/88
US Classification:
424/450000, 514/044000, 435/458000
Abstract:
This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, or an infectious disease. Also disclosed are therapeutic compositions useful in such a method.

Vaccines Using Pattern Recognition Receptor-Ligand:lipid Complexes

US Patent:
2005001, Jan 20, 2005
Filed:
Jul 14, 2003
Appl. No.:
10/621254
Inventors:
Steven Dow - Littleton CO, US
Jeffery Fairman - Mountain View CA, US
International Classification:
A61K039/395
US Classification:
424144100
Abstract:
This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, an infectious disease, or a condition associated with a deleterious activity of a self-antigen. Also disclosed are therapeutic compositions useful in such a method.

Systemic Immune Activation Method Using Non Cpg Nucleic Acids

US Patent:
2005018, Aug 18, 2005
Filed:
Feb 17, 2004
Appl. No.:
10/780294
Inventors:
Steven Dow - Littleton CO, US
Jeffery Fairman - Mountain View CA, US
International Classification:
A61K048/00
A61K009/127
US Classification:
424450000, 514044000
Abstract:
This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, or an infectious disease. Also disclosed are therapeutic compositions useful in such a method.

Vaccines Using Nucleic Acid-Lipid Complexes

US Patent:
2009016, Jun 25, 2009
Filed:
Mar 6, 2009
Appl. No.:
12/399896
Inventors:
Steven W. Dow - Littleton CO, US
Robyn E. Elmslie - Littleton CO, US
Jurgen Karl Johannes Schwarze - Witten, DE
ERwin W. Gelfand - Englewood CO, US
Assignee:
NATIONAL JEWISH MEDICAL AND RESEARCH - Denver CO
International Classification:
A61K 9/127
A61K 39/00
A61P 37/02
US Classification:
424450, 4241931
Abstract:
This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, an infectious disease, or a condition associated with a deleterious activity of a self-antigen. Also disclosed are therapeutic compositions useful in such a method.

Isbn (Books And Publications)

Understanding The Law: Principles, Problems, And Potentials Of The American Legal System

Author:
Steven Dow
ISBN #:
0314045805

Breeding Angelfish For The Hobbyist And Professional

Author:
Steven Dow
ISBN #:
0668040556

Success With Corydoras Catfish

Author:
Steven Dow
ISBN #:
0915096005

Breeding Angelfish For The Hobbyist And Professional

Author:
Steven Dow
ISBN #:
0915096048

Possible Relatives

Cynthia L Dow  David H Dow  Dawn Dow  Dale R Dow  Dana L Dow  Daniel G Dow  Dee Dow  Steven D Johnson  Steven B Standiford  Steven B Standley 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.